HARVARD BIOSCIENCE INC — Director's Dealing 2020

Jun 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2020-06-18

Reporting Person: Eade Katherine A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-18	Common Stock	A	28100	$0.00	Acquired	168915	Direct

Footnotes

F1: Represents an award of 28,100 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after June 11, 2020, immediately prior to the commencement of such meeting, and (ii) June 18, 2021.

F2: Includes (a) the award described in footnote (1) above, (b) a restricted stock unit award of 14,475 remaining unvested restricted stock units vesting in equal quarterly installments on June 30, 2020, September 30, 2020 and December 31, 2020, and (c) 126,340 shares of common stock held by the Reporting Person.